Literature DB >> 3181330

Studies on the mercapturic acid pathway in the rabbit lens.

S Iwata1, T Maesato.   

Abstract

We have examined the mercapturic acid pathway of the cataractous rabbit lens following induction by naphthalene as an oxidative foreign substance. 1,2-Naphthoquinone, which is formed in the eye from naphthalene diol and other naphthalene derivatives by a combination of enzymic and non-enzymic reactions, readily oxidizes GSH and GSH S-transferase [EC 2.5.1.18] in the lens scavenging system. 1,2-Naphthoquinone appeared in the rabbit aqueous humor after 8 h, and showed a maximum level in the lens 24 h after naphthalene administration, with marked accumulation in the lens nucleus. At the same time, the GSH level and GSH S-transferase activity in the lens decreased after 4 h, and lens opacification appeared 7 days after naphthalene administration. Furthermore, we identified the naphthalene metabolite, N-acetyl-S-(1,2-dihydro-2-hydroxynaphthyl) cysteine, in the lens of rabbit after naphthalene administration and in an in vitro experiment on lens homogenate using gas chromatography-mass spectrometry (GC-MS). This compound is an intermediate of the mercapturic acid pathway, and indicates that naphthalene derivatives are metabolized through the mercapturic acid pathway which acts as a scavenging system in the lens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181330     DOI: 10.1016/0014-4835(88)90058-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

1.  Influence of galactose cataract on erythrocytic and lenticular glutathione metabolism in albino rats.

Authors:  M Jyothi; R Sanil; S Shashidhar
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

2.  Effect of Kohl-Chikni Dawa - a compound ophthalmic formulation of Unani medicine on naphthalene-induced cataracts in rats.

Authors:  Tariq Akram Siddiqui; Shadab Zafar; Nishat Iqbal; Ayasha Nadeem; Zehra Zaidi; Shareef Haider Alavi
Journal:  BMC Complement Altern Med       Date:  2002-12-29       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.